Brahmi Private Label Manufacturing in India: The B2B Guide for 2026
Brahmi is one of the easiest Ayurvedic herbs to turn into a compliant, differentiated private-label product, provided the extract is specified correctly from day one. This brahmi private label manufacturing guide is written for Indian MLM companies, D2C founders and distributors who want to add a memory or focus SKU without building a factory. It covers formats, specifications, MOQs, indicative pricing, compliance, quality control and timelines, with every number labelled as a source figure or an industry estimate.
Why Brahmi Works as a Private-Label Hero Ingredient
Three things make brahmi (Bacopa monnieri) attractive for a contract-manufactured line. It is domestically grown, so raw-material supply is stable and priced in rupees. It is a listed botanical under FSSAI’s Schedule IV, so the food-supplement route is open without novel-food approval. And it carries a body of placebo-controlled human trials, including a 9-trial meta-analysis, that supports carefully worded memory and attention claims.
It also fits several customer journeys that MLM and direct-selling teams already sell into: students and exam preparation, working professionals seeking focus, and the 55+ memory-support segment. If you are new to the herb, read our brahmi complete guide first; the Hinglish brahmi business and profit guide covers the investment side.
Formats You Can Manufacture Under Private Label
Capsules
HPMC or gelatin, 250–500 mg extract or 500 mg powder per capsule, 30/60/90-count bottles or blister strips. Fastest to launch, longest shelf life (24 months), easiest to export.
Tablets
Compressed 500–1,000 mg tablets, film-coated to mask bitterness. Lower unit cost at volume; tooling and setup push MOQ to 2,000–5,000 units (industry estimate).
Syrups and drops
Brahmi syrup (often with shankhpushpi and ashwagandha) in 200 ml bottles for children and students; 30 ml drops for premium positioning. Needs preservative system and flavour masking.
Powders and blends
Brahmi churna, ‘brain tonic’ powders and sachets. Suits Ayurvedic catalogues and MLM starter kits; MOQ from 300–500 packs (industry estimate).
For a first brahmi private label manufacturing project, capsules are the pragmatic choice: no flavour work, the smallest MOQ, the longest shelf life and the simplest label. Syrups make sense once a brand has a children’s or student audience and the volume to justify a 1,000-bottle run. Tablets pay off only at scale, where the per-unit saving of a few rupees outweighs the higher first-run commitment.
Hair oils and shampoos are a fourth option and run through the cosmetics licence rather than FSSAI. They are discussed on our personal care page and are not covered in detail here.
Specifications and Standardisation: Getting the Extract Right
The specification you write determines your cost, your claims and your legal exposure. The table below summarises the common grades in the Indian B2B market and what each is good for.
| Grade | Standardisation | Assay method | Indicative B2B price (₹/kg) | Suits |
|---|---|---|---|---|
| Brahmi powder (whole plant) | None; identity by macroscopy and TLC | TLC fingerprint | 150–350 (industry estimate) | Churna, syrup base, economy capsules |
| Brahmi extract 10:1 / 20% bacosides | 20% total bacosides | UV spectrophotometry | 900–1,500 (industry estimate) | Mass-market capsules, syrups |
| Brahmi extract 45–55% bacosides | 45–55% total bacosides | UV; HPLC on request | 1,800–3,200 (industry estimate) | Premium nootropic SKUs |
| HPLC 5-peak extract | Specified bacoside A3, bacopaside II, X, bacopasaponin C | HPLC | 2,500–4,000 (industry estimate) | Science-led D2C, export |
| Branded (CDRI-08, Bacognize, Synapsa, BacoMind) | Supplier-defined, trial-backed | HPLC | Quote-based | Brands citing clinical studies |
For a 300 mg daily dose of a 50% extract, the trial-matched benchmark, a 60-capsule bottle needs only 18 g of extract. Even at ₹3,000 per kg that is ₹54 of active per bottle, which is why brahmi supports premium positioning at modest cost.
MOQs, Indicative Pricing and a Per-Bottle Cost Build
Minimum order quantities depend more on packaging than on the herb. Capsule lines can run small batches; tablets and syrups need larger runs to amortise setup. The figures below are industry estimates for a GMP contract manufacturer in North India in late 2026.
| Cost component (60 × 500 mg caps, 20% extract) | Approx. ₹ per bottle |
|---|---|
| Brahmi extract 20% (30 g at ₹1,200/kg) | 36 |
| Excipients, blending, encapsulation | 8–12 |
| HPMC capsule shells (60) | 9–13 |
| HDPE bottle, cap, seal, label, carton | 20–32 |
| QC testing and documentation (amortised) | 6–10 |
| Manufactured cost | 79–103 |
| GST 5% (herbal supplement) | 4–5 |
| Freight and warehousing | 10–15 |
| Landed cost to brand | 93–123 |
At an MRP of ₹449–599 for a 60-capsule bottle, which is where most branded brahmi products sit on Indian marketplaces, a landed cost of about ₹100 leaves room for distributor commissions, platform fees and company margin. Premium HPLC products retail at ₹799–1,299.
Two levers move the cost build most. Packaging accounts for a quarter to a third of the landed cost, so a standard 100 cc HDPE bottle with a printed label is far cheaper than a custom glass jar with a sleeve. And the extract grade decides whether the active ingredient costs ₹20 or ₹60 per bottle. Decide what your customer will pay for before you decide what the formula contains.
The Private-Label Process, Step by Step
The step most brands underestimate is artwork. Every claim, every ingredient name and every mandatory declaration is checked against FSSAI and Legal Metrology rules before printing, and changes after plate-making are expensive. Agree the label text before the design agency starts.
Documents the brand should have ready before production starts: company registration and GST, FSSAI registration or licence (or the application acknowledgement), trademark application for the brand name, approved artwork files, and a signed manufacturing agreement that states who owns the formula, who holds retained samples and how complaints are handled. Brahmi private label manufacturing runs smoothly when these are in place; most delays we see are paperwork, not production.
Compliance and Labelling for Brahmi Products
Most private-label brahmi supplements are sold under the FSSAI health-supplement or nutraceutical category. The manufacturer’s FSSAI licence covers production; the brand owner needs its own FSSAI registration or licence as a marketer or relabeller, with the manufacturer listed. Classical Ayurvedic brahmi medicines are a separate route under a state AYUSH drug licence.
- Mandatory label elements: product name and category (‘Health Supplement’), ingredient list with botanical name and plant part, quantity of bacopa extract per serving, recommended daily use, ‘NOT FOR MEDICINAL USE’, ‘not to exceed the stated recommended daily usage’, net quantity, batch, manufacturing and expiry dates, manufacturer and marketer addresses, both FSSAI licence numbers, veg logo, MRP and consumer-care details.
- Dose: keep the daily bacopa quantity within the Schedule IV usage range for Bacopa monnieri and consistent with trial doses (about 300 mg of a 50% extract or equivalent).
- Claims: structure-function wording only (‘supports memory and concentration’, ‘traditionally used as a medhya rasayana’). No ‘cures’, ‘treats’, ‘prevents’ or named diseases.
- Target groups: add ‘not recommended for pregnant or lactating women or children below (age) unless advised’ unless your product is specifically formulated and approved for children.
- Direct selling: if sold through MLM, the Consumer Protection (Direct Selling) Rules, 2021 make the company responsible for distributor claims; include claim guidance in training material.
A practical tip for brahmi private label manufacturing: write the label copy as if an FSSAI inspector and a sceptical pharmacist will both read it. Name the plant, the part, the extract ratio and the bacoside content; cite ‘traditionally used’ rather than ‘clinically proven’ unless you hold the trial on the exact extract and dose you are selling.
Quality Control and Testing Protocol
A credible brahmi COA covers identity, potency, purity and safety. Ask your manufacturer for the following on every batch, and keep the reports for the shelf life of the product plus one year.
| Test | Method | Why it matters for brahmi |
|---|---|---|
| Botanical identity | Macroscopy, TLC/HPTLC against reference | Rules out Centella asiatica substitution |
| Bacoside assay | UV or HPLC (state which) | Supports the percentage printed on the label |
| Heavy metals (Pb, As, Cd, Hg) | ICP-MS or AAS | Wetland herbs can accumulate metals from water and soil |
| Pesticide residues | GC-MS / LC-MS multi-residue | Cultivated brahmi may receive sprays near harvest |
| Microbial limits | TPC, yeast and mould, E. coli, Salmonella, S. aureus | Fresh herb is dried in the open in many supply chains |
| Aflatoxins | HPLC | Required for FSSAI compliance on botanicals |
| Disintegration / weight variation | Pharmacopoeial | Capsule and tablet performance |
Start Your Brahmi Private-Label Project
Tell us the format, dose, extract grade and quantity you have in mind. MLM Products Manufacturer will send a costed proposal, sample timeline and label checklist for your brahmi capsules, tablets, syrup or powder.
Brahmi Private Label FAQs
What is the minimum order for private-label brahmi capsules in India?
Most GMP contract manufacturers start brahmi capsule runs at 500–1,000 bottles of 60 capsules (industry estimate, 2026). Powders and churna can start around 300–500 packs, syrups at 1,000–2,000 bottles and tablets at 2,000–5,000 units because of tooling and coating setup. Smaller pilot runs are sometimes possible at a higher unit cost.
How much does it cost to manufacture a bottle of brahmi capsules?
For 60 capsules of 500 mg 20% bacoside extract, the manufactured cost is roughly ₹79–103 per bottle and the landed cost about ₹93–123 after 5% GST and freight (industry estimate, November 2026). A plain powder capsule lands near ₹55–75 and a 50% HPLC extract product near ₹120–160. Packaging choices move the number more than the herb does.
Which brahmi extract grade should a new brand choose?
For a mass-market or MLM catalogue product, a 20% bacoside extract (UV) at 300–500 mg per capsule is the cost-effective norm. For a science-led D2C brand that wants to reference clinical trials, choose a 45–55% extract with an HPLC profile, or a branded extract such as CDRI-08 or Bacognize, and dose at the trial-matched 300 mg per day.
Do I need my own FSSAI licence for a private-label brahmi supplement?
Yes. The manufacturer’s licence covers production, but the brand that owns the label needs its own FSSAI registration or licence as a marketer or relabeller, and both licence numbers appear on the pack. If you sell nationally through e-commerce or MLM, a central licence is usually appropriate. Your contract manufacturer can guide the application.
Can my label say brahmi improves memory?
You may use structure-function wording such as ‘supports memory and concentration’ or ‘traditionally used to support cognitive function’, provided the dose is within the FSSAI Schedule IV range and the product carries ‘NOT FOR MEDICINAL USE’. You may not claim it treats or prevents Alzheimer’s disease, dementia, ADHD or any other condition, and distributors must follow the same rule.
How long does a brahmi private-label launch take?
Allow 8–14 weeks from brief to dispatch for a new SKU: about two weeks for sampling, two to three weeks for artwork and compliance review, and two to three weeks for production and QC, with the balance in approvals and raw-material lead time. Repeat orders take 4–6 weeks. A brand without an FSSAI licence should add 4–8 weeks.
- Kongkeaw C et al. Meta-analysis of RCTs on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol 2014
- Calabrese C et al. Standardized Bacopa monnieri extract in the elderly, RCT. J Altern Complement Med 2008
- FSSAI: FAQs on Nutraceutical Regulations (health supplements, nutraceuticals, Schedule IV botanicals)
- FSSAI enforces labelling rules for Schedule IV plant nutraceuticals, Oct 2026
- National Medicinal Plants Board: Brahmi cultivation and yield
- IndiaMART brahmi herb listings (price reference, Nov 2026)
- Consumer Protection (Direct Selling) Rules, 2021, Department of Consumer Affairs
